David joined HERC as a Researcher in October 2016. He has worked on a variety of projects spanning multiple disease areas and methodologies, ranging from the use of expert elicitation to identify diagnostic pathways in non-alcoholic fatty liver disease to within trial analysis of phase 3 randomised trials in oncology.
In his DPhil project, David seeks to continue his work on the comparative assessment of new advanced radiotherapy technologies. This will be done through the development of microsimulation models as well as trial and registry data analysis across a variety of cancer sites.
David's academic background is in Economics, receiving his Bachelor’s Degree in the subject from the University of York. He continued at the University, completing a Master’s Degree in Health Economics with support from a National Institute of Health Research studentship. Prior to joining HERC David worked as a Health Economist Intern at The Global Fund in Geneva. His research looked at estimating the effect of Human Rights interventions on the health and behaviour of marginal population groups in low and middle income countries.
Individualised Estimation of Quality-adjusted Survival Benefit and Cost-effectiveness of Proton Beam Therapy in Intermediate-stage Hodgkin Lymphoma
Jones DA. et al, (2023), Clinical Oncology
P095: Personalised Modelling of Quality-Adjusted Survival Benefit and Cost-Effectiveness of using Proton Beam Therapy inthe Treatment of Intermediate-Stage Hodgkin Lymphoma in England
Jones D. et al, (2022), HemaSphere, 6, 43 - 44
Informing Radiotherapy Decisions in Stage I/IIa Hodgkin Lymphoma: Modelling Life Expectancy Using Radiation Dosimetry.
Jones DA. et al, (2021), Blood Adv